OpenLegislation

Article 9 Information required to monitor tradeF1

United Kingdom

Original text. Later amendments are not shown.

1.

For the purposes of Article 8(2) of Regulation (EC) No 273/2004 operators shall inform the competent authorities in a summary form of the quantities of scheduled substances used or supplied and, in the case of supply, of the quantity supplied to each third party.

For scheduled substances of Category 3 of Annex I to Regulation (EC) No 273/2004, the first paragraph shall apply only upon request by the competent authorities.

2.

For the purposes of Article 9(2) of Regulation (EC) No 111/2005, operators shall inform the competent authorities about the following:

(a)

exports of scheduled substances subject to an export authorisation;

(b)

all imports of scheduled substances of Category 1 of the Annex to Regulation (EC) No 111/2005 requiring an import authorisation or all cases where scheduled substances of Category 2 of the Annex to Regulation (EC) No 111/2005 are entered into F2a special customs procedure other than transit, or released for free circulation;

(c)

all intermediary activities involving scheduled substances of Categories 1 and 2 of the Annex to Regulation (EC) No 111/2005.

3.

The information referred to in paragraph 2(a) shall be organised by making reference to the countries of destination F3or Northern Ireland, quantities exported and the reference numbers of the export authorisations as the case may be.

4.

The information referred to in paragraph 2(b) shall be organised by making reference to the third country of export F4or Northern Ireland and the reference number of the import authorisations as the case may be.

5.

The information referred to in paragraph 2(c) shall be organised by making reference to the third countries F5or Northern Ireland involved in these intermediary activities and the export or import authorisation as the case may be. Operators shall provide further information, upon request of the competent authorities.

6.

The competent authorities shall treat the information referred to in this Article as confidential business information.

Annotations

Textual amendments

F1

Regulation revoked (N.I.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), reg. 1(1), Sch.

F2

Words in Art. 9(2)(b) substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 15(4); 2020 c. 1, Sch. 5 para. 1(1)

F3

Words in Art. 9(3) inserted (E.W.S.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 7(4)(a)

F4

Words in Art. 9(4) inserted (E.W.S.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 7(4)(b)

F5

Words in Art. 9(5) inserted (E.W.S.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 7(4)(c)